Sponsor study identifier
interventional
10
1 country
1
Study Start
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures. This is a crossover, controlled, clinical trial in which children with esophageal stricture will be randomized in two groups to receive either topical mitomycin or no additional treatment during standard esophageal dilation session.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
October 30, 2007
Actual (reported)October 31, 2007
Actual (reported)December 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Number of days with improved symptom (dysphagia) after dilation session.
14 days
Esophageal diameter
14 days
First dilation session with topical mitomycin applied over esophageal mucosa after dilation. Second dilation session (after 14 days): standard dilation without topical mitomycin.
First dilation session: standard dilation without topical mitomycin. Second dilation session (after 14 days) with topical mitomycin applied over esophageal mucosa after dilation.
Esophageal dilation session with topical mitomycin applied over esophageal mucosa after dilation.
Hospital São Paulo
São Paulo, São Paulo, 04024-002, Brazil
Rodrigo S Machado, PhD
Disciplina de Gastroenterologia Pediátrica, UNIFESP/EPM
First Submitted
October 30, 2007
First Posted
October 31, 2007
Study Start
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Estimated (date passed)Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 9, 2008
Record last verified: 2007-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: